Ticovac 1.2MCG/0.25 1S
Ended Awarded
- Contract number
- SPE2DX26FKUMK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,891
Award facts
- Contract value 100% obligated
- $1,890.54 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,890.54 to DMS Pharmaceutical Group Inc. for TICOVAC 1.2MCG/0.25 1S, a vaccine product. The award, issued on October 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, leveraging the company's established capacity as a critical pharmaceutical supplier. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected based on competitive merit without restriction limitations.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. The underlying IDC, designated contract SPE2DR and awarded November 13, 2025, carries a ceiling value of $499.999 billion through December 31, 2036, establishing DMS Pharmaceutical Group as a regional prime vendor contractor authorized to deliver comprehensive pharmaceutical products including vaccines, prescription medications, biologics, and medical consumables to military healthcare operations globally. The company's performance on numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DX26FKUMK?
SPE2DX26FKUMK was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 24, 2025.
How much is contract SPE2DX26FKUMK worth?
The government has obligated $1,891 on SPE2DX26FKUMK.
Is contract SPE2DX26FKUMK an order under another contract?
Yes. SPE2DX26FKUMK is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX26FKUMK competed?
The extent of competition for SPE2DX26FKUMK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award